Abionyx Pharma SA (ABNX) — Financial Flexibility Index
Abionyx Pharma SA (ABNX) has a Financial Flexibility Index of -0.20x as of June 2025. Free cash flow of €-1.54 Million (operating CF €-1.70 Million minus capex €162.00K) represents 0% of total liabilities (€7.56 Million). Also explore Abionyx Pharma SA annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Abionyx Pharma SA Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Abionyx Pharma SA across 12 annual periods. Check Abionyx Pharma SA strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Abionyx Pharma SA (2013–2024)
Year-by-year free cash flow to debt coverage for Abionyx Pharma SA. For the full company profile including market capitalisation, see ABNX company net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.58x | €-3.52 Million | €-3.60 Million | €6.03 Million | ▼ -13.3% |
| 2023 | -0.52x | €-3.57 Million | €-3.70 Million | €6.91 Million | ▼ -40.3% |
| 2022 | -0.37x | €-3.18 Million | €-3.36 Million | €8.65 Million | ▲ +37.1% |
| 2021 | -0.59x | €-6.53 Million | €-6.69 Million | €11.15 Million | ▼ -374.6% |
| 2020 | -0.12x | €-451.00K | €-599.00K | €3.66 Million | ▲ +88.5% |
| 2019 | -1.07x | €-3.85 Million | €-3.95 Million | €3.58 Million | ▼ -67.0% |
| 2018 | -0.64x | €-5.98 Million | €-6.00 Million | €9.30 Million | ▲ +31.9% |
| 2017 | -0.94x | €-8.88 Million | €-9.09 Million | €9.41 Million | ▲ +28.9% |
| 2016 | -1.33x | €-19.19 Million | €-19.20 Million | €14.46 Million | ▼ -26.6% |
| 2015 | -1.05x | €-13.54 Million | €-13.71 Million | €12.91 Million | ▼ -244.1% |
| 2014 | -0.30x | €-3.30 Million | €-3.30 Million | €10.82 Million | ▲ +83.7% |
| 2013 | -1.87x | €-14.48 Million | €-14.49 Million | €7.76 Million | — |